生物模擬市場：按產品/服務、應用、分銷管道和地區分類

Biosimulation Market, By Product and Services, By Application, By Distribution Channel, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 159 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，生物模擬市場規模將達到32.741億美元，2033年將達到103.678億美元。預計從2026年到2033年，其複合年成長率將達到17.9%。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	32.741億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	17.90%	預計金額（2033 年）	103.678億美元

生物模擬是一種利用電腦模擬技術來模擬人體生物過程、系統和路徑的方法。這有助於我們了解人體在分子和細胞層面的功能，以及藥物和醫療設備等特定醫療介入措施在其中的作用機制。透過模擬疾病機制、進展以及與治療性介入在不同尺度（從分子到組織）上的相互作用，生物模擬有助於減少藥物研發過程中對大規模實驗室和臨床試驗的需求。這最終能夠節省成本、提高效率並加快藥物發現速度。

市場動態

全球生物模擬市場的成長主要受以下因素驅動：製藥和生物技術產業研發投入的增加、對降低藥物研發成本和縮短研發週期的日益重視、個人化醫療的普及、慢性病盛行率的上升以及生物模擬領域的技術快速發展。然而，市場成長可能受到IT基礎設施不足和缺乏操作複雜生物模擬工具及模型所需專業人才的限制。該市場的主要機會在於生物模擬應用領域的不斷拓展，包括疫苗研發、膳食和毒理學分析、組織工程和個人化醫療，以及產業界和學術機構為進一步推進技術進步而開展的持續合作。

近年來，全球生物模擬市場取得了顯著的技術進步，創造了新的機會和應用領域。生物模擬利用電腦建模和模擬來研究和預測生物過程。這使得研究人員能夠模擬從細胞、組織到整個生物體的生物系統，從而更深入地了解疾病並測試新的藥物治療方法。

本報告的主要特點

本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
本節根據公司概況、產品系列、主要亮點、財務表現和策略等各種參數，對全球生物模擬市場中的主要公司進行介紹。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
《全球生物模擬市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球生物模擬市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第8章競爭情勢

Certara, LP
Simulations Plus, Inc.
Dassault Systemes（Accelrys）
Genedata AG
LeadScope, Inc.
Compugen Inc.
Schrodinger, LLC
In Silico Biosciences, Inc.
Advanced Chemistry Development, Inc.
Chemical Computing Group ULC
Physiomics PLC
Pharmaceutical Product Development, LLC（Evidera）

第9章

分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI2016

Biosimulation Market is estimated to be valued at USD 3,274.1 Mn in 2026 and is expected to reach USD 10,367.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 17.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3,274.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	17.90%	2033 Value Projection:	USD 10,367.8 Mn

Biosimulation is a computational model that is used to simulate biological processes, systems, and pathways of the human body using computer simulations. It aids in understanding how the body functions at molecular and cellular levels and how certain medical interventions such as drugs or medical devices are likely to behave in it. By simulating disease mechanisms, progressions and their interaction with therapeutic interventions at various scales from molecule to tissue, biosimulation aids in reducing the need for extensive laboratory and clinical testing during drug development processes. This leads to lower costs, greater efficiency, and faster drug discovery.

Market Dynamics

Global biosimulation market growth is driven by factors such as rising R&D expenditure in pharmaceutical and biotechnology industries, growing emphasis on reducing drug development costs and time, increasing adoption of personalized medicine, growing prevalence of chronic diseases, and rapid technological advancements in field of biosimulation. However, the market growth can be restrained due to lack of competent IT infrastructure and skilled professionals required for handling complex biosimulation tools and models. Major opportunity for this market lies in growing application areas of biosimulation including vaccine development, dietary and toxicity analysis, tissue engineering, personalized medicine, and others and ongoing collaborations between industries and academic institutions for further advancement of technology.

Global biosimulation market has witnessed tremendous technological progress in the recent years, and this offers new opportunities and applications. Biosimulation uses computer modeling and simulation to study and predict biological processes. It allows researchers to simulate biological systems like cells, tissues and entire organisms to better understand disease and test new drug treatments.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global biosimulation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Certara, L.P., Simulations Plus, Inc., Dassault Systemes (Accelrys), Genedata AG, LeadScope, Inc., Compugen Inc., Schrodinger, LLC, In Silico Biosciences, Inc., Advanced Chemistry Development, Inc., Chemical Computing Group ULC, Physiomics PLC, and Pharmaceutical Product Development, LLC (Evidera)
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global biosimulation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biosimulation market

Market Segmentation

By Product and Services (Revenue, USD Mn, 2021 - 2033)
Software
Services
By Application (Revenue, USD Mn, 2021 - 2033)
Drug Discovery
Drug Development
By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Certara, L.P.
Simulations Plus, Inc.
Dassault Systemes (Accelrys)
Genedata AG
LeadScope, Inc.
Compugen Inc.
Schrodinger, LLC
In Silico Biosciences, Inc.
Advanced Chemistry Development, Inc.
Chemical Computing Group ULC
Physiomics PLC
Pharmaceutical Product Development, LLC (Evidera).

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Biosimulation Market Snippet, By Product and Services
- Global Biosimulation Market Snippet, By Application
- Global Biosimulation Market Snippet, By Distribution Channel
- Global Biosimulation Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Biosimulation Market, By Product and Services, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

5. Global Biosimulation Market, By Application, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Drug Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

6. Global Biosimulation Market, By Distribution Channel, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

7. Global Biosimulation Market, By Region, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2021 - 2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Mn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Certara, L.P.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Simulations Plus, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Dassault Systemes (Accelrys)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Genedata AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
LeadScope, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Compugen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Schrodinger, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
In Silico Biosciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Advanced Chemistry Development, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Chemical Computing Group ULC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Physiomics PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pharmaceutical Product Development, LLC (Evidera)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views